Immunetrics’ disease models span across acute inflammation, chronic, autoimmune conditions, and immuno-oncology.

These models can be customized to meet specific needs and are constantly evolving to support new research outcomes.


 

Disease Models

 

Key Outputs

 

Supported Therapeutics

Rheumatoid Arthritis

 

 

Swollen/tender joint counts

ACR20/50/70

DAS28(3)-CRP/ESR

Low disease activity

Remission

Serum cytokines and biomarkers

Serum cell counts

MTX

5-ASA

Corticosteroids

JAK inhibitors

Anti-TNFs

Anti-IL6s

Anti-IL17s

Anti-T and B cell therapies

Anti-Survival therapies

Anti-Migration therapies

Psoriatic Arthritis / Psoriasis

Swollen/tender joint counts

ACR20/50/70

DAS28(3)-CRP/ESR

PASI 50/75/90/100

Serum cytokines and biomarkers

Serum cell counts

MTX

5-ASA

Corticosteroids

JAK inhibitors

Anti-TNFs

Anti-IL6s

Anti-IL17s

Anti-IL12/23

Anti-T and B cell therapies

Anti-Survival therapies

Anti-Migration therapies

Ulcerative Colitis

Mayo score

Response/Remission

Mucosal healing

Serum cytokines and biomarkers

MTX

5-ASA

Corticosteroids

Anti-TNFs

JAK inhibitors

S1P receptor antagonist

Immuno-oncology

 Melanoma

 Lymphoma

 Leukemia

RECIST criteria

Lesion size changes

Serum cytokines and biomarkers

 

 Proprietary

Sepsis

Multi-Organ Dysfunction

 

Mean arterial pressure (MAP)

Central venous pressure (CVP)

Blood oxygen saturation (O2sat)

Breathing frequency

Tidal volume

Blood gases (PaO2, PaCO2)

Creatinine

Urinary output (UOP)

Coagulation proteins

Fluid therapy

Vasopressors

Ventilators

Diuretics

Dialysis

Antibiotics

Trauma

Cytokines

Immune cells

Coagulation proteins

Blood loss

Mean arterial pressure (MAP)

Blood oxygen saturation (O2sat)

Fluid therapies

Blood products

Ventilators